Vírus Oncogênicos e Câncer Prof. Dr. Aguinaldo Roberto Pinto Laboratório de Imunologia Aplicada MIP/CCB/UFSC Câncer • Hipócrates, por volta do ano 400 a.C • Câncer:…

Yaso Natkunam MD PhD Stanford University An Update Outline •  WHO 2008: New strides in recognition of early lesions, molecular subtypes and borderline categories • …

Therapy of Relapsed or Refractory Aggressive Lymphomas Treatment approaches to non-Hodgkin’s lymphoma in elderly patients Larry W. Kwak, M.D., Ph.D. Chairman, Department…

Slide 1 Evolving Management of Follicular Lymphoma HUMC Oncology Fall Conference November 3, 2011 Hackensack, NJ Myron S. Czuczman, MD Chief, Lymphoma/Myeloma Service Head,…

What are DNA Vaccines? DNA Vaccines Genetic/ DNA immunization is a novel technique used to efficiently stimulate humoral and cellular immune responses to protein antigens.…

1. OVERVIEW of THE IMMUNE SYSTEM DiseasesImmunocompetence/ImmunodeficiencyInfectious DiseaseInflammation AllergyOrgan-Specific Immunologic DisordersConnective Tissue DisordersImmunohematologyTransplantation…

1. Melanoma and the “Magic Bullet” (Monoclonal Antibodies)Author:Jim BreitfellerThis paper is dedicated to Leanne Schmall A patient who lost her battle with the Beast,Melanoma.I.…

1. Antigen Presented by: Samir abo zyd. Mohamed Ibrahim. Reham gamal. Mohamed ahmed Mansour. Ahmed attia. 2. Outlines: I. Antigen receptors. II. Antigen recognition by lymphocytes.…

1. CELLS & ORGANS OFTHE IMMUNE SYSTEM A PresentationBy Isaac U.M., Associate Professor & HOD, Dept. of Microbiology. College of Medicine, International Medical &…

1. Specific Immunity 2. Who are the players? Antigens:foreign proteins, usually part of virus or bacteria Antibodies:Proteins made by immune cells that “recognize” or…